Xention and Grünenthal enter Drug Discovery Collaboration in Ion Channel Research
XENTION LTD announced that it has entered into a Research Agreement with the Grünenthal Group. Under the terms of the Agreement, Xention and Grϋnenthal will combine their respective expertise in ion channel drug discovery and pain therapy to collaborate in the identification of new drugs to ... more
Alberto Grua Head of Grünenthal Europe and Australia
Alberto Gruahas been appointed Grünenthal Europe and Australia Executive Vice President. Beyond the responsibility of the Grünenthal subsidiaries Grünin both continents, Grua will be also a member of the Group Operating Committee of Grünenthal Corporation.
Previously, Grua was Responsible ... more
Grünenthal Pharma produces for Biofrontera
Biofrontera AG and Grünenthal Pharma AG will in the future cooperate on product manufacturing. The companies Biofrontera Pharma GmbH and Grünenthal Pharma AG have signed an agreement for the production of Biofrontera's products BF-200 ALA and Reliéva. BF-200 ALA is a dermatological drug f ... more